| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/14/2001 | CA2243570C Mixture of recombinant vaccinia vectors as polyenv vaccines for hiv |
| 08/14/2001 | CA2185155C Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
| 08/14/2001 | CA2037959C Cyclohexapeptides compound |
| 08/14/2001 | CA2032035C Fungal expression system |
| 08/14/2001 | CA1341285C Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines |
| 08/14/2001 | CA1341284C Site-directed mutagenesis modified glycoprotein hormones and methods of use |
| 08/14/2001 | CA1341283C Biological pesticides and methods for their delivery and use |
| 08/10/2001 | CA2331876A1 Water-soluble ligand-binding proteins and analogs of ligand-gated channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 08/09/2001 | WO2001057278A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human hela cells or other human cervical epithelial cells |
| 08/09/2001 | WO2001057277A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human fetal liver |
| 08/09/2001 | WO2001057276A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow |
| 08/09/2001 | WO2001057275A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human brain |
| 08/09/2001 | WO2001057274A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human heart |
| 08/09/2001 | WO2001057273A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human adult liver |
| 08/09/2001 | WO2001057272A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human placenta |
| 08/09/2001 | WO2001057271A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human breast and bt 474 cells |
| 08/09/2001 | WO2001057270A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human breast and hbl 100 cells |
| 08/09/2001 | WO2001057267A1 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 08/09/2001 | WO2001057266A1 Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides |
| 08/09/2001 | WO2001057262A1 Methods and materials relating to neuronal guidance molecule-like (ngm-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057261A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057260A1 Methods and materials relating to scavenger receptor-like polypeptides and polynucleotides |
| 08/09/2001 | WO2001057257A2 Isolation and identification of mrnas correlating to secreted proteins |
| 08/09/2001 | WO2001057252A2 Methods and apparatus for high-throughput detection and characterization of alternatively spliced genes |
| 08/09/2001 | WO2001057251A2 Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence |
| 08/09/2001 | WO2001057242A2 Methods of protein destabilization and uses thereof |
| 08/09/2001 | WO2001057234A2 Biopolymer thickener |
| 08/09/2001 | WO2001057233A2 Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057228A1 Methods for treatment of restenosis using adenoviral vectors and transgene products |
| 08/09/2001 | WO2001057226A1 Humanized anti-ccr2 antibodies and methods of use therefor |
| 08/09/2001 | WO2001057219A2 Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods |
| 08/09/2001 | WO2001057218A1 A process for producing purified biologically active, free form of recombinant human interferon gamma |
| 08/09/2001 | WO2001057217A1 Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same |
| 08/09/2001 | WO2001057216A2 Method for the production of a protein |
| 08/09/2001 | WO2001057215A2 Human g-protein coupled receptor polypeptides and polynucleotides having homology with odorant receptors |
| 08/09/2001 | WO2001057214A2 Human transporter proteins and polynucleotides encoding the same |
| 08/09/2001 | WO2001057213A2 Human bcl-x-like proteins and polynucleotides encoding the same |
| 08/09/2001 | WO2001057211A1 Soluble t cell receptor protein and method of constructing the same |
| 08/09/2001 | WO2001057210A2 Use of dendroaspin as a vehicle for non-dendroaspin domains |
| 08/09/2001 | WO2001057209A2 Novel family of proteins, called atip, nucleic sequences coding for same and uses thereof |
| 08/09/2001 | WO2001057208A2 Mlp gene, nucleic acids, polypeptides and the utilization thereof |
| 08/09/2001 | WO2001057207A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 08/09/2001 | WO2001057203A1 NOVEL GENE tig104α AND PROTEIN TIG104α ENCODED THEREBY |
| 08/09/2001 | WO2001057202A2 Evi27 gene sequences and protein encoded thereby |
| 08/09/2001 | WO2001057201A2 Root transcriptional factors and methods of use |
| 08/09/2001 | WO2001057200A2 Root transcriptional factors and methods of use |
| 08/09/2001 | WO2001057190A2 Novel nucleic acids and polypeptides |
| 08/09/2001 | WO2001057189A2 Fas pathway genes |
| 08/09/2001 | WO2001057187A2 Novel bone marrow nucleic acids and polypeptides |
| 08/09/2001 | WO2001057186A2 Methods and compositions for diagnosis and treatment of cancer based on esf |
| 08/09/2001 | WO2001057185A2 Novel molecules of the card-related protein family and uses thereof |
| 08/09/2001 | WO2001057183A2 Method for producing circular or multimeric protein species in vivo or in vitro and related methods |
| 08/09/2001 | WO2001057182A2 Nucleic acids, proteins, and antibodies |
| 08/09/2001 | WO2001057175A2 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 08/09/2001 | WO2001057091A1 Soluble, chimeric transcription factors that enter cells to modulate cell differentiation and phenotype |
| 08/09/2001 | WO2001057088A1 RUMINANT MHC CLASS I-LIKE Fc RECEPTORS |
| 08/09/2001 | WO2001057087A2 High affinity immunoglobulin epsilon receptor beta-subunit-like protein and nucleic acids encoding same |
| 08/09/2001 | WO2001057086A2 Novel human g protein coupled receptor proteins and polynucleotides encoding the same |
| 08/09/2001 | WO2001057085A2 G-protein coupled receptors |
| 08/09/2001 | WO2001057084A1 Crystallisation of a glp-1 analogue |
| 08/09/2001 | WO2001057083A1 Methods for promoting growth of bone, ligament, and cartilage using zvegf4 |
| 08/09/2001 | WO2001057082A2 Extraction of growth factors from tissue |
| 08/09/2001 | WO2001057080A2 Neuropeptide-like polypeptide zpep17 |
| 08/09/2001 | WO2001057079A2 C1 inhibitor produced in the milk of transgenic mammals |
| 08/09/2001 | WO2001057078A1 Process for producing dialytic amyloid fiber polymerization nuclei, method of screening remedies for dialytic amyloidosis and remedies for dialytic amyloidosis |
| 08/09/2001 | WO2001057077A1 Proteins that are specifically expressed or highly overexpressed in tumors and nucleic acids encoding them |
| 08/09/2001 | WO2001057076A1 Method of purifying a hydrophobin present in a hydrophobin-containing solution |
| 08/09/2001 | WO2001057075A2 Virulence genes, proteins, and their use |
| 08/09/2001 | WO2001057074A1 Ligands for fpr class receptors that induce a host immune response to a pathogen or inhibit hiv infection |
| 08/09/2001 | WO2001057073A2 Infectious cdna clone of hepatitis e virus (hev) genome, its production and uses |
| 08/09/2001 | WO2001057072A2 Pharmacologically active antiviral peptides and methods of their use |
| 08/09/2001 | WO2001057070A1 Melanin-concentrating hormone analogs |
| 08/09/2001 | WO2001057068A1 Mucin-1 derived antigens and their use in immunotherapy |
| 08/09/2001 | WO2001057067A1 Ligand for vascular endothelial growth factor receptor |
| 08/09/2001 | WO2001057065A2 Combinatorial protein domains |
| 08/09/2001 | WO2001057063A1 Eto1 and related proteins, and methods of regulating ethylene biosynthesis |
| 08/09/2001 | WO2001057062A1 Modulation of osf-2 in inflammatory and renal diseases |
| 08/09/2001 | WO2001057060A1 Bcl-2-like polynucleotides, polypeptides, and antibodies |
| 08/09/2001 | WO2001056627A1 Medical device coated with antimicrobial peptides |
| 08/09/2001 | WO2001056605A1 Porin b (porb) as a threrapeutic target for prevention and treatment of infection by chlamydia |
| 08/09/2001 | WO2001056598A2 Methods for preventing or attenuating pathoangiogenic conditions by using gbs-toxin (cm101) |
| 08/09/2001 | WO2001056591A1 vMIP-II PEPTIDE ANTAGONISTS OF CXCR4 |
| 08/09/2001 | WO2001056376A1 Transgenic non-human animal overexpressing gli-1, as a cancer model system |
| 08/09/2001 | WO2001056375A1 Tob gene-defective knockout nonhuman mammal |
| 08/09/2001 | WO2001056355A2 Human immunodeficiency virus vaccine |
| 08/09/2001 | WO2001030964A3 Anti-cancer nucleic acid and protein targets |
| 08/09/2001 | WO2001027335A8 A novel adjuvant |
| 08/09/2001 | WO2001021796A3 Gl50 molecules and uses therefor |
| 08/09/2001 | WO2001021217A3 Method of treating cells of the prostate prophylactically or therapeutically |
| 08/09/2001 | WO2001020008A3 Vascular-specific promoters |
| 08/09/2001 | WO2001019989A3 Method of producing and purifying endostatintm protein |
| 08/09/2001 | WO2001010901A3 Antimicrobial histone h1 compositions, kits, and methods of use thereof |
| 08/09/2001 | WO2001007622A3 DNA SEQUENCES THAT ENCODE TYPE II (xcp) SECRETION SYSTEMS |
| 08/09/2001 | WO2001007587A3 Dna sequences coding for iron and heavy metal transporters |
| 08/09/2001 | WO2001006988A3 Super-active porcine growth hormone releasing hormone analog |
| 08/09/2001 | WO2001005951A3 Novel sgs3 plant gene and use thereof |
| 08/09/2001 | WO2001005945A3 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 08/09/2001 | WO2001004318A3 Myxoma virus genes for immune modulation |
| 08/09/2001 | WO2001004316A3 Antigenic meningococcal peptides |
| 08/09/2001 | WO2001002590A3 Plants with modified gene expression |